CD8A and neoplasm: To assess whether B7H4-mediated immune suppression can be reversed by the adoptive transfer of antigen-specific CD8 T cells, EG7-B7H4 and EG7-mock tumor-bearing mice were intravenously injected with activated CD8 OT-I cells on day 10.